Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis

BACKGROUND: Non‐vitamin K antagonist oral anticoagulants (NOACs) have better pharmacologic properties than warfarin and are recommended in preference to warfarin in most patients with non‐valvular atrial fibrillation. Besides lower bleeding complications, other advantages of NOACs over warfarin part...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Am Heart Assoc
Päätekijät: Sitticharoenchai, Patita, Takkavatakarn, Kullaya, Boonyaratavej, Smonporn, Praditpornsilpa, Kearkiat, Eiam‐Ong, Somchai, Susantitaphong, Paweena
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Systematic Review and Meta‐analysis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174352/
https://ncbi.nlm.nih.gov/pubmed/33728927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.019609
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia